🔗 Share this article

As America continues making unprecedented revisions to its vaccine guidelines, an unexpected name has emerged in a surprising turn: Tracy Beth Høeg, a Danish American physician and epidemiologist who initially gained attention by questioning coronavirus vaccinations throughout the global health crisis and has concentrated on potential deaths after COVID-19 immunization in her brief time at the US Food and Drug Administration (FDA).

Planned Overhauls to Pediatric Vaccine Schedule

Public health authorities planned to reveal radical revisions to the pediatric immunization program earlier this month, synchronizing the US with Denmark’s vaccine program, it is understood – a substantial departure that would place the US out of step with much of the global community with no evidence for public health gain. This reveal has been pushed back until the coming year.

Instead of Vinay Prasad, Tracy Beth Høeg is scheduled to address the audience at the gathering. She was recently named temporary leader of the FDA’s CDER, the fifth appointee to head the office this calendar year.

Consolidating Power at the Agency

The acting appointment could signify a strengthened alliance between the drug and vaccine centers as Dr. Høeg and Prasad strengthen their influence at the FDA – and it suggests a renewed priority upon reevaluating long-standing immunizations at the FDA.

Dr. Høeg has repeatedly called for discontinuing certain pediatric immunization guidelines in the US in order to be more in line with Denmark, a country with universal health coverage and a citizenry about the population of Wisconsin’s.

So far public appearances, she has kept her attention on vaccination policy – typically the domain of Prasad, director of the FDA’s vaccine center – instead of medication approval.

Doubts Over Expertise

The appointee has no apparent background in drug development, approval processes or leadership, which has been customary for previous directors of the Center for Biologics Evaluation and Research. She has worked at the FDA as a key advisor to the FDA chief and the vaccine center since earlier this year.

“It seems she lacks to have any of the qualifications” for leading the drug-regulation department, remarked Jonathan Howard. “She’s never run a randomized controlled trial. She is not versed in leading a sizeable institution. She is not an expert in industry regulation.”

Past commissioners of the center would “grasp legal statutes and the underlying principles of medication creation”, said Dr. Janet Woodcock. “Clearly, she lacks the type of experience that former directors who headed the center have had.”

The drug center has an vast range of responsibilities at the agency, Woodcock pointed out.

“The public just pays attention on the innovative therapies, but the generic drug division clears a multitude of generic drugs. There is also a biosimilars division, OTC medication office and other areas, and every single one have to be supervised,” she noted. “The area you overlook, that is precisely what that I always told people is going to bite you.”

Additionally, a significant leadership component to the position, which manages more than 5,000 employees. “It is a huge leadership role, if you do it right,” Woodcock said.

Official Statement and Contentious Policies

In response to concerns about Dr. Høeg's credentials and whether this assignment represents more teamwork among FDA leaders on vaccines, a spokesperson stated that the “questions stem from flawed presumptions”.

“This background matches the responsibilities of her role,” the spokesperson stated, citing the months Høeg spent counseling the FDA commissioner on “medication safety and regulatory science, including computational safety modeling and immunization monitoring”.

In her interim role, Dr. Høeg takes over the commissioner’s controversial fast-track approval initiative, a contentious rapid therapy clearance system that allegedly troubled her predecessors. “How are these therapies being chosen for this expedited pathway? Who takes the calls?” Dr. Howard said. “There is a lot of lack of transparency occurring at the agency right now.”

In general, he said, “the agency looks to be trending towards less stringent rules of most medications, aside from shots.”

Documented History on Vaccines

Concerning immunizations, Dr. Høeg has a more established, if concerning, track record, critics said. She published a study using unverified public submissions to assess the incidence of heart inflammation following Covid immunization. She advised the state of Florida top health official Dr. Joseph Ladapo, who allegedly have altered data to suggest Covid vaccines are pose a greater threat than they are.

Among her “policy goals” for the current administration encompassed revising guidelines for novel immunizations and ending “unnecessary” immunizations, she stated after the election on a online show. At the agency, Høeg has allegedly suggested excluding adolescent males from receiving COVID-19 vaccines.

“She’s an thorough true believer who commences with her beliefs and reverse-engineers to fit the science in a very deceptive, untruthful way,” Howard argued.

Taking Control and a “Campaign of Retribution”

Dr. Høeg joined fellow skeptics, {like|